Proposed mechanisms for the induction of insulin resistance by oxidative stress

被引:311
作者
Bloch-Damti, A [1 ]
Bashan, N [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Soroka Med Ctr, IL-84105 Beer Sheva, Israel
关键词
D O I
10.1089/ars.2005.7.1553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In diabetes (type I and type 2), increased flux of free fatty acids and glucose is associated with increased mitochondrial reactive oxygen species (ROS) production and, as a consequence, increased oxidative stress. ROS have been shown to activate various cellular stress-sensitive pathways, which can interfere with cellular signaling pathways. Exposure of different cell lines to micromolar concentrations of hydrogen peroxide leads to the activation of stress kinases such as c-Jun N-terminal kinase, p38, I kappa B kinase, and extracellular receptor kinase 1/2. This activation is accompanied by a down-regulation of the cellular response to insulin, leading to a reduced ability of insulin to promote glucose uptake, and glycogen and protein synthesis. The mechanisms leading to this down-regulation in oxidized cells are complicated, involving increased serine/threonine phosphorylation of insulin receptor substrate-1 (IRS1), impaired insulin-stimulated redistribution of IRS1 and phosphatidylinositol-kinase between cytosol and low-density microsomal fraction, followed by a reduced protein kinase-B phosphorylation and GLUT4 translocation to the plasma membrane. In addition, prolonged exposure to ROS affects transcription of glucose transporters: whereas the level of GLUT1 is increased, GLUT4 level is reduced. As can be expected, administration of antioxidants such as lipoic acid in oxidized cells, in animal models of diabetes, and in type 2 diabetes shows improved insulin sensitivity. Thus, oxidative stress is presently accepted as a likely causative factor in the development of insulin resistance.
引用
收藏
页码:1553 / 1567
页数:15
相关论文
共 166 条
[91]   GLYOXALASE SYSTEM IN CLINICAL DIABETES-MELLITUS AND CORRELATION WITH DIABETIC COMPLICATIONS [J].
MCLELLAN, AC ;
THORNALLEY, PJ ;
BENN, J ;
SONKSEN, PH .
CLINICAL SCIENCE, 1994, 87 (01) :21-29
[92]   Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus [J].
Muchová, J ;
Liptáková, A ;
Országhová, Z ;
Garaiová, I ;
Tison, P ;
Cársky, J ;
Duracková, Z .
DIABETIC MEDICINE, 1999, 16 (01) :74-78
[93]   Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage [J].
Nishikawa, T ;
Edelstein, D ;
Du, XL ;
Yamagishi, S ;
Matsumura, T ;
Kaneda, Y ;
Yorek, MA ;
Beebe, D ;
Oates, PJ ;
Hammes, HP ;
Giardino, I ;
Brownlee, M .
NATURE, 2000, 404 (6779) :787-790
[94]   Relationships between plasma measures of oxidative stress and metabolic control in NIDDM [J].
NouroozZadeh, J ;
Rahimi, A ;
TajaddiniSarmadi, J ;
Tritschler, H ;
Rosen, P ;
Halliwell, B ;
Betteridge, DJ .
DIABETOLOGIA, 1997, 40 (06) :647-653
[95]   Oxidative stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase [J].
Ogihara, T ;
Asano, T ;
Katagiri, H ;
Sakoda, H ;
Anai, M ;
Shojima, N ;
Ono, H ;
Fujishiro, M ;
Kushiyama, A ;
Fukushima, Y ;
Kikuchi, M ;
Noguchi, N ;
Aburatani, H ;
Gotoh, Y ;
Komuro, I ;
Fujita, T .
DIABETOLOGIA, 2004, 47 (05) :794-805
[96]   Depletion of total antioxidant capacity in type 2 diabetes [J].
Opara, EC ;
Abdel-Rahman, E ;
Soliman, S ;
Kamel, WA ;
Souka, S ;
Lowe, JE ;
Abdel-Aleem, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (11) :1414-1417
[97]   THIOCTIC (LIPOIC) ACID - A THERAPEUTIC METAL-CHELATING ANTIOXIDANT [J].
OU, PM ;
TRITSCHLER, HJ ;
WOLFF, SP .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (01) :123-126
[98]   A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1 [J].
Ozes, ON ;
Akca, H ;
Mayo, LD ;
Gustin, JA ;
Maehama, T ;
Dixon, JE ;
Donner, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4640-4645
[99]   ALPHA-LIPOIC ACID AS A BIOLOGICAL ANTIOXIDANT [J].
PACKER, L ;
WITT, EH ;
TRITSCHLER, HJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (02) :227-250
[100]   Molecular aspects of lipoic acid in the prevention of diabetes complications [J].
Packer, L ;
Kraemer, K ;
Rimbach, G .
NUTRITION, 2001, 17 (10) :888-895